SCHEMBL19781108

SCHEMBL19781108

NCCOCCOC1OC(COC(=O)c2ccccc2)C(O)C(OC(=O)c2ccccc2)C1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LGALS9 O00182 1/20 0.41
▸ LGALS1 P09382 1/20 0.41
▸ LGALS3 P17931 1/20 0.41
▸ LGALS7; LGALS7B P47929 1/20 0.41
▸ MAOB P27338 1/20 0.39
▸ PTPN1 P18031 3/20 0.39
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ TMPRSS2 O15393 1/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ HMGCR P04035 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ HSPD1 P10809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14978161 0.86 USP2 (0.50) USP2MEN1POLBKMT2APTPN1
SCHEMBL10177584 0.86 USP2 (0.50) USP2MEN1POLBKMT2APTPN1
SCHEMBL21101101 0.86 USP2 (0.50) USP2MEN1POLBKMT2APTPN1
SCHEMBL22389307 0.85 KMT2A (0.42) USP2MEN1POLBKMT2ALGALS9
SCHEMBL17073898 0.82 LGALS3 (0.46) USP2MEN1POLBKMT2ALGALS9
SCHEMBL24496369 0.80 NT5E (0.46) USP2MEN1POLBKMT2ALGALS9
SCHEMBL6220071 0.80 PTPN1 (0.53) USP2MEN1POLBKMT2ALGALS9
SCHEMBL6220068 0.80 PTPN1 (0.53) USP2MEN1POLBKMT2ALGALS9
SCHEMBL19786838 0.79 PTPN1 (0.47) USP2MEN1POLBKMT2ALGALS9
SCHEMBL19781228 0.79 LMNA (0.49) USP2MEN1POLBKMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10781175-B2 Solid supports and phosphoramidite building blocks for oligonucleotide conjugates AM CHEMICALS LLC (US) 2020-09-22 — — US disclosed
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES AM CHEMICALS LLC (US) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781175-B2 Solid supports and phosphoramidite building blocks for oligonucleotide conjugates NCL, PAICS, RTCB USP2 4525/4885MEN1 2389/4885POLB 14/4885
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES NCL, PAICS, RTCB USP2 4525/4885MEN1 2389/4885POLB 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback